Author

Lilli Bonstingl

Medical University of GrazORCID 0009-0009-0757-6962Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell-cell communication· 2 Organism:human· 2 Assay:spatial transcriptomics· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Assay:CITE-seq· 1 Research Focus:differential expression· 1

Frequent Co-Authors

Amin El HeliebiiD· 2 shared Ellen HeitzeriD· 2 shared Karin Pankratz· 2 shared Katja SallingeriD· 2 shared Anatol Borrás-CherrieriD· 1 shared Antonia SyrniotiiD· 1 shared Christin-Therese Müller· 1 shared Christina Skofler· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Amin El HeliebiORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintNov 28, 2025

Tissue architecture and immune niches govern ctDNA release in colorectal cancer

Stefan Kühberger, Katja Sallinger, Christin-Therese Müller…·Ellen Heitzer

This study identifies tissue architecture and immune niches as key factors influencing ctDNA release in colorectal cancer by integrating spatial transcriptomics and in situ mutation detection.

DOI 10.1101/2025.11.28.691139

humanspatial transcriptomics

𝕏 PostBluesky

Molecular BiologybioRxivPreprintMay 8, 2024

Circulating tumor cell characterization and classification by novel combinatorial dual-color (CoDuCo) in situ hybridization and supervised machine learning

Lilli Bonstingl, Margret Zinnegger, Katja Sallinger…·Amin El Heliebi

The paper develops a novel CoDuCo in situ hybridization method combined with machine learning to classify and characterize circulating tumor cells in prostate cancer, identifying resistance mechanisms and therapeutic targets.

2 citations

humanCITE-seq

𝕏 PostBluesky